Macquarie Group’s Heliogen, Inc. HLGN Stock Holding History

Macquarie Group’s Portfolio HLGN Stock Details HLGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-27,971	Closed	-$9.72M	–	2656
2021 Q3	$9.72M	Buy	+27,971	New	+$9.69M	0.01%	931

Other funds holding HLGN

PML

Prime Movers Lab Jackson, Wyoming $13.5M AUM 0% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SCA

Salient Capital Advisors Houston, Texas $1.74B AUM 12.95% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

SCM

Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return

Altshuler Shaham Tel Aviv, Israel $5.54B AUM 44.68% 1-Year Est. Return

NZS Capital Denver, Colorado $3B AUM 21.29% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Macquarie Group's HLGN Position: Q4 2021 in Review

Macquarie Group sold out of Heliogen, Inc. (HLGN) in Q4 2021, closing a stake of 27,971 shares — an estimated $9.72M sold.

Macquarie Group first reported a position in HLGN in Q3 2021 and held it in 1 quarter. The position peaked at $9.72M in Q3 2021. 25 funds tracked by Wall St. Rank hold HLGN as of Q4 2021.

Macquarie Group reported no remaining Heliogen, Inc. position as of Q4 2021 after selling out during the quarter.
Macquarie Group sold 27,971 Heliogen, Inc. shares in Q4 2021, an estimated $9.72M.
Macquarie Group first reported a position in Heliogen, Inc. in Q3 2021 and held it in 1 quarter.
Macquarie Group's Heliogen, Inc. position peaked at $9.72M in Q3 2021.
25 funds tracked by Wall St. Rank held Heliogen, Inc. as of Q4 2021.

Based on Macquarie Group's 13F filing for Q4 2021, filed 11 Feb 2022.